OncoMEDx, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for OncoMEDx, Inc..The latest application filed is for "analysis of apoptotic bodies in bodily fluids".

Company Profile

0.21.13

OncoMEDx, Inc. - Hackettstown NJ US
OncoMEDx, Inc. - Long Valley NJ
OncoMEDx, Inc - Long Valley NJ
ONCOMEDX, INC. - 23 Wellington Drive Long Valley NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Analysis of Apoptotic Bodies in Bodily Fluids App 20160222462 - Kopreski; Michael S.	2016-08-04
Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma or serum to detect, monitor or evaluate cancer or premalignant conditions Grant 8,809,020 - Kopreski August 19, 2	2014-08-19
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 8,440,396 - Kopreski May 14, 2	2013-05-14
Comparative analysis of extracellular RNA species Grant 8,163,524 - Kopreski April 24, 2	2012-04-24
Methods for detecting and monitoring cancer using extracellular RNA Grant 8,043,835 - Kopreski October 25, 2	2011-10-25
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 8,030,031 - Kopreski October 4, 2	2011-10-04
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 7,972,817 - Kopreski July 5, 2	2011-07-05
Detection of 5T4 RNA in plasma and serum Grant 7,968,317 - Kopreski , et al. June 28, 2	2011-06-28
Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma of serum to detect, monitor or evaluate cancer or premalignant conditions Grant 7,932,061 - Kopreski April 26, 2	2011-04-26
Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum Grant 7,910,336 - Kopreski , et al. March 22, 2	2011-03-22
Comparative analysis of extracellular RNA species Grant 7,785,842 - Kopreski August 31, 2	2010-08-31
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 7,767,423 - Kopreski August 3, 2	2010-08-03
Detection of 5T4 RNA in plasma and serum Grant 7,767,422 - Kopreski , et al. August 3, 2	2010-08-03
Methods for evaluating drug-resistance gene expression in the cancer patient Grant 7,767,390 - Kopreski August 3, 2	2010-08-03
Method for Detection of DNA Methyltransferase RNA in Plasma and Serum App 20100159464 - Kopreski; Michael S.	2010-06-24
Methods for evaluating drug-resistance gene expression in the cancer patient Grant 7,732,141 - Kopreski June 8, 2	2010-06-08
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 7,709,233 - Kopreski May 4, 2	2010-05-04
Methods for Analysis of Extracelluar RNA Species App 20090291438 - Kopreski; Michael S.	2009-11-26
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions App 20090233276 - Kopreski; Michael S.	2009-09-17
Analysis of Extracellular RNA App 20090136942 - Kopreski; Michael S.	2009-05-28
Method for Detection of DNA Methyltransferase RNA in Plasma and Serum App 20080286784 - Kopreski; Michael S.	2008-11-20
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions App 20080261292 - Kopreski; Michael S.	2008-10-23
Methods for Evaluating Drug-Resistance Gene Expression in the Cancer Patient App 20080254457 - Kopreski; Michael S.	2008-10-16
Methods for Detecting and Monitoring COX-2 RNA in Plasma and Serum App 20080207723 - Kopreski; Michael S.	2008-08-28
Method for detection of 5T4 RNA in plasma or serum App 20080200410 - Kopreski; Michael S. ; et al.	2008-08-21
Methods for evaluating pathologic conditions using extracellular RNA App 20080096217 - Kopreski; Michael S.	2008-04-24
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions App 20080057502 - Kopreski; Michael S.	2008-03-06
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer App 20080050783 - Kopreski; Michael S.	2008-02-28
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 6,939,671 - Kopreski September 6, 2	2005-09-06
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 6,916,634 - Kopreski July 12, 2	2005-07-12
Method for detection of 5T4 RNA in plasma or serum Grant 6,794,135 - Kopreski , et al. September 21, 2	2004-09-21
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 6,759,217 - Kopreski July 6, 2	2004-07-06
Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum Grant 6,607,898 - Kopreski , et al. August 19, 2	2003-08-19
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Grant 6,329,179 - Kopreski December 11, 2	2001-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.